Back to mobile site

Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues

December 28, 2017 4:08 PM EST

Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Earnings, Guidance

Related Entities

Earnings